XWELL ROE 2010-2024 | XWEL
Current and historical return on equity (ROE) values for XWELL (XWEL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| XWELL ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $-0.02B | $0.02B | -83.33% |
| 2024-06-30 | $-0.02B | $0.02B | -104.76% |
| 2024-03-31 | $-0.03B | $0.02B | -100.00% |
| 2023-12-31 | $-0.03B | $0.02B | -90.63% |
| 2023-09-30 | $-0.04B | $0.03B | -95.48% |
| 2023-06-30 | $-0.03B | $0.04B | -67.37% |
| 2023-03-31 | $-0.03B | $0.04B | -58.37% |
| 2022-12-31 | $-0.03B | $0.05B | -46.04% |
| 2022-09-30 | $-0.02B | $0.06B | -19.39% |
| 2022-06-30 | $-0.00B | $0.08B | -3.23% |
| 2022-03-31 | $0.00B | $0.09B | 1.04% |
| 2021-12-31 | $0.00B | $0.10B | 4.04% |
| 2021-09-30 | $-0.01B | $0.10B | -14.89% |
| 2021-06-30 | $-0.03B | $0.09B | -31.52% |
| 2021-03-31 | $-0.08B | $0.10B | -121.80% |
| 2020-12-31 | $-0.09B | $0.08B | -221.95% |
| 2020-09-30 | $-0.08B | $0.06B | -409.88% |
| 2020-06-30 | $-0.08B | $0.03B | -1171.43% |
| 2020-03-31 | $-0.03B | $-0.00B | -1933.33% |
| 2019-12-31 | $-0.02B | $-0.00B | -400.00% |
| 2019-09-30 | $-0.02B | $0.01B | -227.03% |
| 2019-06-30 | $-0.02B | $0.01B | -158.33% |
| 2019-03-31 | $-0.02B | $0.01B | -117.24% |
| 2018-12-31 | $-0.04B | $0.01B | -220.29% |
| 2018-09-30 | $-0.04B | $0.02B | -164.71% |
| 2018-06-30 | $-0.04B | $0.02B | -123.94% |
| 2018-03-31 | $-0.05B | $0.02B | -106.21% |
| 2017-12-31 | $-0.03B | $0.05B | -53.95% |
| 2017-09-30 | $-0.02B | $0.06B | -37.77% |
| 2017-06-30 | $-0.02B | $0.05B | -43.14% |
| 2017-03-31 | $-0.03B | $0.06B | -57.46% |
| 2016-12-31 | $-0.02B | $0.06B | -59.63% |
| 2016-09-30 | $-0.00B | $0.03B | -11.59% |
| 2016-06-30 | $-0.01B | $0.03B | -34.38% |
| 2016-03-31 | $-0.01B | $0.04B | -30.51% |
| 2015-12-31 | $-0.01B | $0.04B | -46.15% |
| 2015-09-30 | $-0.10B | $0.02B | -442.55% |
| 2015-06-30 | $-0.10B | $0.02B | -228.57% |
| 2015-03-31 | $-0.11B | $0.03B | -152.17% |
| 2014-12-31 | $-0.11B | $0.03B | -121.11% |
| 2014-09-30 | $-0.05B | $0.11B | -46.95% |
| 2014-06-30 | $-0.05B | $0.11B | -43.59% |
| 2014-03-31 | $-0.05B | $0.11B | -42.45% |
| 2013-12-31 | $-0.05B | $0.11B | -40.77% |
| 2013-09-30 | $-0.05B | $0.13B | -34.66% |
| 2013-06-30 | $-0.04B | $0.14B | -31.13% |
| 2013-03-31 | $-0.03B | $0.14B | -32.89% |
| 2012-12-31 | $-0.02B | $0.15B | -35.29% |
| 2012-09-30 | $-0.01B | $0.09B | -25.26% |
| 2012-06-30 | $-0.00B | $-0.00B | -800.00% |
| 2012-03-31 | $-0.00B | $0.00B | -1600.00% |
| 2011-12-31 | $-0.00B | $0.01B | 1200.00% |
| 2011-09-30 | $-0.01B | $-0.00B | 333.33% |
| 2011-06-30 | $-0.01B | $-0.00B | 933.33% |
| 2011-03-31 | $-0.01B | $-0.00B | -2000.00% |
| 2010-12-31 | $-0.01B | $0.00B | -1466.67% |
| 2010-06-30 | $-0.01B | $0.00B | -1066.67% |
| 2010-03-31 | $-0.00B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.006B | $0.030B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.685B | 28.04 |
| Elevance Health (ELV) | United States | $90.559B | 11.84 |
| Cencora (COR) | United States | $47.572B | 17.32 |
| Natera (NTRA) | United States | $23.122B | 0.00 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| ICON (ICLR) | Ireland | $16.164B | 14.40 |
| Avantor (AVTR) | United States | $14.769B | 22.14 |
| Revvity (RVTY) | United States | $14.502B | 24.32 |
| BioMerieux (BMXMF) | France | $14.256B | 0.00 |
| Viatris (VTRS) | United States | $13.010B | 4.01 |
| Solventum (SOLV) | United States | $12.919B | 0.00 |
| CochLear (CHEOY) | Australia | $12.848B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.220B | 31.61 |
| Doximity (DOCS) | United States | $10.877B | 56.56 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.037B | 0.00 |
| HealthEquity (HQY) | United States | $9.712B | 48.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.513B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.502B | 16.43 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $5.661B | 26.33 |
| BrightSpring Health Services (BTSG) | United States | $3.913B | 83.22 |
| Sotera Health (SHC) | United States | $3.909B | 20.91 |
| Organon (OGN) | United States | $3.835B | 3.87 |
| Surgery Partners (SGRY) | United States | $3.260B | 37.17 |
| Concentras Parent (CON) | United States | $2.958B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.885B | 0.00 |
| PACS (PACS) | United States | $2.161B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.061B | 0.00 |
| Progyny (PGNY) | United States | $1.859B | 37.64 |
| GoodRx Holdings (GDRX) | United States | $1.837B | 48.20 |
| Premier (PINC) | United States | $1.821B | 11.08 |
| GeneDx Holdings (WGS) | United States | $1.708B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Agilon Health (AGL) | United States | $1.351B | 0.00 |
| CareDx (CDNA) | United States | $1.217B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.177B | 11.51 |
| Embecta (EMBC) | United States | $1.031B | 7.06 |
| AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
| Establishment Labs Holdings (ESTA) | $0.848B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.602B | 0.00 |
| SBC Medicals (SBC) | United States | $0.533B | 0.00 |
| DocGo (DCGO) | United States | $0.501B | 18.89 |
| Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.435B | 0.00 |
| Enhabit (EHAB) | United States | $0.414B | 35.83 |
| QDM (QDMI) | Hong Kong, SAR China | $0.382B | 10.00 |
| MultiPlan (MPLN) | United States | $0.352B | 0.00 |
| Nutex Health (NUTX) | United States | $0.323B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.317B | 0.00 |
| LifeMD (LFMD) | United States | $0.270B | 0.00 |
| Beauty Health (SKIN) | United States | $0.201B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.159B | 0.00 |
| Biodesix (BDSX) | United States | $0.151B | 0.00 |
| So-Young (SY) | China | $0.104B | 17.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
| Oncology Institute (TOI) | United States | $0.067B | 0.00 |
| ModivCare (MODV) | United States | $0.062B | 3.35 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |